Screening of cyanobacterial bioactive peptides against viral infections

سال انتشار: 1402
محل انتشار: دوازدهمین همایش ملی و سومین همایش بین المللی بیوانفورماتیک
کد COI اختصاصی: IBIS12_156
زبان مقاله: انگلیسی
تعداد مشاهده: 97

نویسندگان

Department of Biotechnology, Faculty of New Sciences and Technologies, Semnan University, Semnan, Iran

چکیده

The risk of spreading viral infections increasingly threatens public health. Unfortunately, thenumber of effective and available drugs for the prevention and treatment of these types of infections islimited [۱]. Management of viral infections in the absence of prevention tools brings costs and hasserious effects on the economy and social life [۲]. The most effective way to rapidly identify antiviralcompounds is high-throughput screening of the libraries containing existing drugs or random molecules.Such analysis provides potential drug candidates, however, these efforts are usually not cost-effectiveand often time-consuming [۳]. Boosting immunity is a simple way to resist viral infection. The use ofimmune-enhancing nutrients has the potential to control viral infections by activating the immuneresponse. Cyanobacteria are a rich biological source of bioactive compounds with therapeuticimportance [۴]. In this research, among ۶۰ proteins with possible antiviral function, during ۱۰ step bystep screening, ones that had the ability to inactivate ACE۲ enzyme were selected. The ۳ selectedproteins not only represented acceptable biochemical and pharmacokinetic properties, but also hadsignificant binding energy compared to commercial antiviral drugs. Bioactive peptides are defined asspecific protein fragments that have a positive effect on body performance and health. With the help ofbioinformatics tools, it is possible to discover bioactive peptides with enhanced health-care properties,especially against viral infections. The discovery of medicinal metabolites, especially from the branchof aquatic biotechnology, has opened a promising future for us in the face of the spread of drug-resistantstrains .

کلیدواژه ها

drug discovery; viral infections; bioinformatics analysis; bioactive prospecting

مقالات مرتبط جدید

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.